B
23.11
-0.36 (-1.53%)
| Penutupan Terdahulu | 23.47 |
| Buka | 23.21 |
| Jumlah Dagangan | 604,709 |
| Purata Dagangan (3B) | 543,518 |
| Modal Pasaran | 1,512,946,816 |
| Harga / Buku (P/B) | 3.69 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 May 2026 |
| EPS Cair (TTM) | -1.69 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.13% |
| Nisbah Semasa (MRQ) | 24.62 |
| Aliran Tunai Operasi (OCF TTM) | -88.27 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -53.72 M |
| Pulangan Atas Aset (ROA TTM) | -13.84% |
| Pulangan Atas Ekuiti (ROE TTM) | -27.26% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Bicara Therapeutics Inc. | Menaik | Menurun |
AISkor Stockmoo
-0.6
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | -3.5 |
| Volatiliti Harga | -5.0 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | 2.5 |
| Purata | -0.60 |
|
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 11.65% |
| % Dimiliki oleh Institusi | 89.28% |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| HYEP IVAN | - | 23.11 | -9,200 | -212,612 |
| MAZUMDAR CLAIRE | - | 23.47 | -15,000 | -352,050 |
| Jumlah Keseluruhan Kuantiti Bersih | -24,200 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -564,662 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 23.29 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| HYEP IVAN | Pegawai | 21 Apr 2026 | Jual automatik (-) | 9,200 | 23.11 | 212,612 |
| HYEP IVAN | Pegawai | 21 Apr 2026 | Pelaksanaan pilihan | 9,200 | - | - |
| MAZUMDAR CLAIRE | Pegawai | 20 Apr 2026 | Jual automatik (-) | 15,000 | 23.47 | 352,050 |
| MAZUMDAR CLAIRE | Pegawai | 20 Apr 2026 | Pelaksanaan pilihan | 15,000 | - | - |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 05 Feb 2026 | Pengumuman | Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |